BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20802013)

  • 21. Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching.
    Feng D; Yang L; Bi X; Stone RC; Patel P; Barnes BJ
    Eur J Immunol; 2012 Jun; 42(6):1477-87. PubMed ID: 22678902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis.
    Watkins AA; Yasuda K; Wilson GE; Aprahamian T; Xie Y; Maganto-Garcia E; Shukla P; Oberlander L; Laskow B; Menn-Josephy H; Wu Y; Duffau P; Fried SK; Lichtman AH; Bonegio RG; Rifkin IR
    J Immunol; 2015 Feb; 194(4):1467-79. PubMed ID: 25595782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation and role of the transcription factor IRF5 in innate immune responses and systemic lupus erythematosus.
    Ban T; Sato GR; Tamura T
    Int Immunol; 2018 Oct; 30(11):529-536. PubMed ID: 29860420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocytes from Irf5-/- mice have an intrinsic defect in their response to pristane-induced lupus.
    Yang L; Feng D; Bi X; Stone RC; Barnes BJ
    J Immunol; 2012 Oct; 189(7):3741-50. PubMed ID: 22933628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IRF5 is elevated in childhood-onset SLE and regulated by histone acetyltransferase and histone deacetylase inhibitors.
    Shu J; Li L; Zhou LB; Qian J; Fan ZD; Zhuang LL; Wang LL; Jin R; Yu HG; Zhou GP
    Oncotarget; 2017 Jul; 8(29):47184-47194. PubMed ID: 28525378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential T Cell-Intrinsic Regulatory Roles for IRF5 via Cytokine Modulation in T Helper Subset Differentiation and Function.
    Brune Z; Rice MR; Barnes BJ
    Front Immunol; 2020; 11():1143. PubMed ID: 32582209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The
    Devaraju P; Mehra S; Gulati R; Antony PT; Jain VK; Misra DP; Negi VS
    Indian J Med Res; 2018 Jun; 147(6):560-566. PubMed ID: 30168487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.
    Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN
    Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of age-associated B cells by IRF5 in systemic autoimmunity.
    Manni M; Gupta S; Ricker E; Chinenov Y; Park SH; Shi M; Pannellini T; Jessberger R; Ivashkiv LB; Pernis AB
    Nat Immunol; 2018 Apr; 19(4):407-419. PubMed ID: 29483597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function.
    Wen F; Ellingson SM; Kyogoku C; Peterson EJ; Gaffney PM
    Autoimmunity; 2011 Mar; 44(2):82-9. PubMed ID: 20695768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms.
    Hudson CA; Cao L; Kasten-Jolly J; Kirkwood JN; Lawrence DA
    J Toxicol Environ Health A; 2003 May; 66(10):895-918. PubMed ID: 12825236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
    Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
    Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
    Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
    Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
    Graham RR; Kozyrev SV; Baechler EC; Reddy MV; Plenge RM; Bauer JW; Ortmann WA; Koeuth T; González Escribano MF; ; Pons-Estel B; Petri M; Daly M; Gregersen PK; Martín J; Altshuler D; Behrens TW; Alarcón-Riquelme ME
    Nat Genet; 2006 May; 38(5):550-5. PubMed ID: 16642019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen modulation of endosome-associated toll-like receptor 8: an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus.
    Young NA; Wu LC; Burd CJ; Friedman AK; Kaffenberger BH; Rajaram MV; Schlesinger LS; James H; Shupnik MA; Jarjour WN
    Clin Immunol; 2014 Mar; 151(1):66-77. PubMed ID: 24525049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of NZB autoimmunity 2 to Y-linked autoimmune acceleration-induced monocytosis in association with murine systemic lupus.
    Kikuchi S; Santiago-Raber ML; Amano H; Amano E; Fossati-Jimack L; Moll T; Kotzin BL; Izui S
    J Immunol; 2006 Mar; 176(5):3240-7. PubMed ID: 16493085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
    Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
    Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmacytoid dendritic cells from parent strains of the NZB/W F1 lupus mouse contribute different characteristics to autoimmune propensity.
    Zhan Y; Kong I; Chopin M; Macri C; Zhang JG; Xie J; Nutt SL; O'Keeffe M; Hawkins ED; Morand EF; Lew AM
    Immunol Cell Biol; 2020 Mar; 98(3):203-214. PubMed ID: 31916630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis.
    Matta B; Barnes BJ
    Cytokine; 2020 Aug; 132():154731. PubMed ID: 31130331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of epigenetic modifications on the inactive X chromosome and sex-biased gene expression profiles in B cells from NZB/W F1 mice with lupus-like disease.
    Syrett CM; Sierra I; Beethem ZT; Dubin AH; Anguera MC
    J Autoimmun; 2020 Feb; 107():102357. PubMed ID: 31780316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.